BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38695992)

  • 1. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
    Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
    J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
    Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
    Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
    Young T; Velikova G; Liegl G; Rose M; Nolte S;
    Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
    de Ligt KM; Aaronson NK; Liegl G; Nolte S;
    Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC QLQ-C30 general population normative data for the United States.
    Rogge AA; Liegl G; Snyder C; Rose M; Nolte S;
    Eur J Cancer; 2024 May; 202():114030. PubMed ID: 38552543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
    Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
    Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45.
    Åsberg RE; Nilsen M; Hjermstad MJ; Reinertsen KV; Karlsen J; Giskeødegård GF; Reidunsdatter RJ
    Eur J Cancer; 2023 Sep; 190():112943. PubMed ID: 37515905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.
    Juul T; Petersen MA; Holzner B; Laurberg S; Christensen P; Grønvold M
    Qual Life Res; 2014 Oct; 23(8):2183-93. PubMed ID: 24676897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population.
    Michelson H; Bolund C; Nilsson B; Brandberg Y
    Acta Oncol; 2000; 39(4):477-84. PubMed ID: 11041109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.
    Ficko SL; Pejsa V; Zadnik V
    Radiol Oncol; 2019 Sep; 53(3):337-347. PubMed ID: 31553711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.
    Waldmann A; Schubert D; Katalinic A
    PLoS One; 2013; 8(9):e74149. PubMed ID: 24058523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.
    Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Pogoda K; Velikova G; Bjelic-Radisic V; Cardoso F; Brain E; Ignatiadis M; Piccart M; Van Tienhoven G; Mansel R; Wildiers H; Bottomley A;
    Eur J Cancer; 2020 Jan; 125():69-82. PubMed ID: 31838407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
    Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
    BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
    Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
    Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.